CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Edgewise Therapeutics, Inc.

For profitWebsite ↗

Also known as: Edgewise Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 20, 2025

Timeline

2010s

Jun 1, 2017
Edgewise Therapeutics, Inc.— Founded

Drugs by trial phase (4 distinct, 14 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (26)

NCT07177066Lead sponsorPhase 1Aug 20, 2025
NCT07034768Lead sponsorPhase 1Jul 22, 2025
NCT06916897Lead sponsorPhase 1Jan 8, 2025
NCT06916897OfficialPhase 1Jan 8, 2025
NCT06738836Lead sponsorPhase 1Dec 31, 2024
NCT06347159OfficialPhase 2Apr 11, 2024
NCT06347159Lead sponsorPhase 2Apr 11, 2024
NCT06100887Lead sponsorPhase 2Dec 31, 2023
NCT06100887Study chairPhase 2Dec 31, 2023
NCT06066580Lead sponsorPhase 2Nov 2, 2023
NCT06066580Study chairPhase 2Nov 2, 2023
NCT06011317Study directorPhase 1Aug 14, 2023
NCT06011317Lead sponsorPhase 1Aug 14, 2023
NCT05730842Lead sponsorPhase 1Jan 12, 2023
NCT05730842Study chairPhase 1Jan 12, 2023

Details

Founded: Boulder, CO, US Jun 1, 2017
Last known activity: Aug 20, 2025